These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26491788)

  • 1. Novel biomarkers for cardiovascular risk assessment: current status and future directions.
    MacNamara J; Eapen DJ; Quyyumi A; Sperling L
    Future Cardiol; 2015 Sep; 11(5):597-613. PubMed ID: 26491788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying new Risk Markers and Potential Targets: The Value of the Proteome.
    Kontush A
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):13-8. PubMed ID: 26931819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
    Krintus M; Kozinski M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing and assessing cardiovascular biomarkers.
    Dadu RT; Nambi V; Ballantyne CM
    Transl Res; 2012 Apr; 159(4):265-76. PubMed ID: 22424430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk prediction: basic concepts, current status, and future directions.
    Lloyd-Jones DM
    Circulation; 2010 Apr; 121(15):1768-77. PubMed ID: 20404268
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.
    Niiranen TJ; Vasan RS
    Expert Rev Cardiovasc Ther; 2016 Jul; 14(7):855-69. PubMed ID: 27057779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying novel biomarkers for cardiovascular disease risk prediction.
    Ge Y; Wang TJ
    J Intern Med; 2012 Nov; 272(5):430-9. PubMed ID: 22950687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
    Herder C; Karakas M; Koenig W
    Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for cardiovascular risk assessment in autoimmune diseases.
    Teixeira PC; Ferber P; Vuilleumier N; Cutler P
    Proteomics Clin Appl; 2015 Feb; 9(1-2):48-57. PubMed ID: 25523513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers determining cardiovascular risk in patients with kidney disease.
    Siasos G; Tousoulis D; Michalea S; Oikonomou E; Kolia C; Kioufis S; Synetos A; Vlasis K; Papavassiliou AG; Stefanadis C
    Curr Med Chem; 2012; 19(16):2555-71. PubMed ID: 22489717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.
    Percy AJ; Byrns S; Chambers AG; Borchers CH
    Expert Rev Proteomics; 2013 Dec; 10(6):567-78. PubMed ID: 24206229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic markers: Potential candidates for cardiovascular disease.
    Rather RA; Dhawan V
    Int J Cardiol; 2016 Oct; 220():914-23. PubMed ID: 27416153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Exercise on Cardiovascular Biomarkers: New Insights, Recent Data, and Applications.
    Che L; Li D
    Adv Exp Med Biol; 2017; 999():43-53. PubMed ID: 29022256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is proteomics of value in cardiovascular risk assessment?
    Arnold N; Koenig W
    Curr Opin Lipidol; 2019 Dec; 30(6):452-461. PubMed ID: 31577609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for cardiovascular disease: challenges and future directions.
    May A; Wang TJ
    Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.
    Carlquist JF; Muhlestein JB; Anderson JL
    Expert Rev Mol Diagn; 2007 Sep; 7(5):511-7. PubMed ID: 17892360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple biomarkers for the prediction of first major cardiovascular events and death.
    Wang TJ; Gona P; Larson MG; Tofler GH; Levy D; Newton-Cheh C; Jacques PF; Rifai N; Selhub J; Robins SJ; Benjamin EJ; D'Agostino RB; Vasan RS
    N Engl J Med; 2006 Dec; 355(25):2631-9. PubMed ID: 17182988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future directions of cardiovascular risk prediction.
    Smith SC
    Am J Cardiol; 2006 Jan; 97(2A):28A-32A. PubMed ID: 16442934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cardiac biomarkers in cardiovascular disease risk assessment.
    Collinson P
    Curr Opin Cardiol; 2014 Jul; 29(4):366-71. PubMed ID: 24848409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives on bioactivity of olive oil: evidence from animal models, human interventions and the use of urinary proteomic biomarkers.
    Silva S; Combet E; Figueira ME; Koeck T; Mullen W; Bronze MR
    Proc Nutr Soc; 2015 Aug; 74(3):268-81. PubMed ID: 26186673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.